BETESIL 2.250 mg, medicated plaster 8 sachets
Active ingredients: Betamethasone, Betamethasone valerate
Commercialized according to BDPMDispensing in France: Prescription only
Medicated plaster8 sachetscutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BETESIL 2,250 mg, emplâtre médicamenteux
- Pharmaceutical form
- emplâtre médicamenteux(se)
- Route of administration
- cutanée
- Presentation description
- 8 sachet(s) papier polyéthylène aluminium copolymère d'éthylène et d'acide méthacrylique
- Marketing authorisation holder
- IBSA PHARMA SAS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Jan 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65726080CIP73779774CIP133400937797740Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEemplâtre | 1,845 mg · un emplâtre | FT |
| VALÉRATE DE BÉTAMÉTHASONEemplâtre | 2,250 mg · un emplâtre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.